TITLE

The invisible hand of the marketing department

PUB. DATE
July 2002
SOURCE
CMAJ: Canadian Medical Association Journal;7/9/2002, Vol. 167 Issue 1, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Editorial. Addresses concerns in the pharmaceutical industry regarding the development of drugs for less common and rare conditions. Difficulty in getting physicians to prescribe drugs with little benefit to them; Tendency of the drug industry to favor the development of drugs for common ailments.
ACCESSION #
6914932

 

Related Articles

  • The invisible hand of the marketing department.  // CMAJ: Canadian Medical Association Journal;7/9/2002, Vol. 167 Issue 1, p5 

    Editorial. Addresses concerns in the pharmaceutical industry regarding the development of drugs for less common and rare conditions. Difficulty in getting physicians to prescribe drugs with little benefit to them; Tendency of the drug industry to favor the development of drugs for common ailments.

  • High costs prompt some plans to seek savings by splitting pills. Prince, Michael // Business Insurance;8/11/2003, Vol. 37 Issue 32, p4 

    As prescription drug costs continue to escalate, some health plans are looking to have participants split higher-dosage pills as a way to save money. But while some employers encourage this practice as a way to save money, others view the risks as too great. For some popularly prescribed drugs,...

  • 'Irrational' prescription system must be changed.  // British Journal of Nursing;1/10/2002, Vol. 11 Issue 1, p11 

    Reports the need for changing prescription charging system in Great Britain. Description of the system; Trend of prescribing smaller containers of drugs at one time; Factors contributing to ill health.

  • Off-label drugs Question your doctor.  // Consumer Reports;Jun2007, Vol. 72 Issue 6, p47 

    The article discusses the practice of doctors prescribing drugs for ailments that the drugs were not approved to treat. The practice of "off-label" prescription can be dangerous, and it is recommended that patients question their doctors on off-label prescriptions. Doctors are not always aware...

  • Perspectives On The Pharmaceutical Industry. Reinhardt, Uwe E. // Health Affairs;2001 A Primer, p128 

    Characterizes the pharmaceutical industry in the United States. Cost structure of the industry; Effect of drug spending on the economy; Drug spending as a percentage of gross domestic product; Pharmaceutical profits as a source of cost containment; Cost sharing by patients; Price discrimination.

  • Do we pay too much for prescriptions?  // Consumer Reports;Oct93, Vol. 58 Issue 10, p668 

    Examines reasons why prescription drugs are priced highly. Pharmaceutical industry as first targets of health-care reform; Price raising during the 1980s; Profits earned by drug companies; Profits as necessary to attract capital for research and development; Price decisions as within the...

  • Gov't to delay drug price rises. Csonka, Agnes // Budapest Business Journal;06/10/2002, Vol. 10 Issue 27, p4 

    Reports on the Hungarian government's plan of delaying a proposed price increase in prescription drugs receiving state subsidies by six months. Price increase for National Health Fund Administration-subsidized medications by an average of 5 percent; Plans to hike the prices of over-the-counter...

  • Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomes. Ioannides-Demos, L.L.; Ibrahim, J.E.; McNeil, J.J.; Ioannides-Demos, Lisa L; Ibrahim, Joseph E; McNeil, John J // PharmacoEconomics;2002, Vol. 20 Issue 9, p577 

    Pharmaceutical expenditure is rising more rapidly than the general inflation rate in most advanced countries. One strategy that has been introduced to control pharmaceutical costs is reference-based pricing (RBP). Its potential is restricted to those specific segments of the drug market where...

  • Prescription market booms with volume growth accelerating. Roller, Kim // Drug Store News;5/22/2000, Vol. 22 Issue 7, p51 

    Focuses on the retail drug prescription market in 1999 in the United States. Market share of chain drug stores; Increase in mail-order sales; Continued increase in prescription volume; Price increase for branded pharmaceuticals.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics